Invention Grant
- Patent Title: Tricyclic compounds for inhibiting the CFTR channel
- Patent Title (中): 用于抑制CFTR通道的三环化合物
-
Application No.: US14653084Application Date: 2013-12-17
-
Publication No.: US09359381B2Publication Date: 2016-06-07
- Inventor: Mahbub Ahmed , Alexander Ashall-Kelly , Louisa Gueritz , Jeffrey McKenna , Joseph McKenna , Simon Mutton , Rakesh Parmar , Jon Shepherd , Paul Wright
- Applicant: Mahbub Ahmed , Alexander Ashall-Kelly , Louisa Gueritz , Jeffrey McKenna , Joseph McKenna , Simon Mutton , Rakesh Parmar , Jon Shepherd , Paul Wright
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Jing Sun
- International Application: PCT/IB2013/061043 WO 20131217
- International Announcement: WO2014/097148 WO 20140626
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/542 ; A61K31/5025 ; A61K31/551 ; C07D471/14 ; C07D487/14 ; C07D513/14 ; C07D513/00 ; A61K31/55 ; A61K45/06 ; C07D487/22 ; C07D487/04 ; C07D495/14
Abstract:
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Public/Granted literature
- US20150336986A1 TRICYCLIC COMPOUNDS FOR INHIBITING THE CFTR CHANNEL Public/Granted day:2015-11-26
Information query
IPC分类:
